The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021.

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to overlook the biotechnology sector. However, for investors willing to look beyond ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered to tell the biotech sector. Biotech stocks lagged the broader market in ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts. The biotech sector has been a disaster for investors over the past five years going by a 14% ...